{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T11:10:54Z","timestamp":1785928254428,"version":"3.56.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,12,13]],"date-time":"2011-12-13T00:00:00Z","timestamp":1323734400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Drug Metab Pharmacokinet"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1007\/s13318-011-0076-3","type":"journal-article","created":{"date-parts":[[2011,12,12]],"date-time":"2011-12-12T13:45:33Z","timestamp":1323697533000},"page":"211-216","source":"Crossref","is-referenced-by-count":10,"title":["Different effects of dihydropyridine calcium channel antagonists on CYP3A4 enzyme of human liver microsomes"],"prefix":"10.1007","volume":"37","author":[{"given":"Zongling","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sulan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,13]]},"reference":[{"issue":"02","key":"76_CR1","first-page":"145","volume":"8","author":"H Chen","year":"2006","unstructured":"Chen H (2006) Hepatic injury after using levoamlodipine besylate in combination with lovastatin and acipimox. Advers Drug React J 8(02):145","journal-title":"Advers Drug React J"},{"issue":"1","key":"76_CR2","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0022-3565(24)34917-1","volume":"290","author":"S Ekins","year":"1999","unstructured":"Ekins S, Bravi G, Binkley S, Gillespie JS, Ring BJ, Wikel JH, Wrighton SA (1999a) Three- and four-dimensional quantitative structure activity relationship analyses of cytochrome P-450 3A4 inhibitors. J Pharmacol Exp Ther 290(1):429\u2013438","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"76_CR3","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0022-3565(24)35117-1","volume":"291","author":"S Ekins","year":"1999","unstructured":"Ekins S, Bravi G, Wikel JH, Wrighton SA (1999b) Three-dimensional-quantitative structure activity relationship analysis of cytochrome P-450 3A4 substrates. J Pharmacol Exp Ther 291(1):424\u2013433","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"76_CR4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1056-8719(02)00168-5","volume":"46","author":"JL Fayer","year":"2001","unstructured":"Fayer JL, Petullo DM, Ring BJ, Wrighton SA, Ruterbories KJ (2001) A novel testosterone 6 beta-hydroxylase activity assay for the study of CYP3A-mediated metabolism, inhibition, and induction in vitro. J Pharmacol Toxicol Method 46(2):117\u2013123","journal-title":"J Pharmacol Toxicol Method"},{"issue":"17","key":"76_CR5","doi-asserted-by":"crossref","first-page":"8168","DOI":"10.1016\/S0021-9258(18)68457-1","volume":"263","author":"FP Guengerich","year":"1988","unstructured":"Guengerich FP, Bocker RH (1988) Cytochrome P-450-catalyzed dehydrogenation of 1,4-dihydropyridines. J Biol Chem 263(17):8168\u20138175","journal-title":"J Biol Chem"},{"issue":"6","key":"76_CR6","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1021\/jm00110a012","volume":"34","author":"FP Guengerich","year":"1991","unstructured":"Guengerich FP, Brian WR, Iwasaki M, Sari MA, Baarnhielm C, Berntsson P (1991) Oxidation of dihydropyridine calcium channel blockers and analogues by human liver cytochrome P-450 IIIA4. J Med Chem 34(6):1838\u20131844","journal-title":"J Med Chem"},{"key":"76_CR7","doi-asserted-by":"crossref","unstructured":"Gibson GG, Skett P (eds) (1994) Introduction drug metabolism, 2nd edn. Blackie Academic & Professional, London","DOI":"10.1007\/978-1-4899-6844-9"},{"issue":"4","key":"76_CR8","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1021\/ci025661p","volume":"43","author":"B Hemmateenejad","year":"2003","unstructured":"Hemmateenejad B, Akhond M, Miri R, Shamsipur M (2003) Genetic algorithm applied to the selection of factors in principal component-artificial neural networks: application to QSAR study of calcium channel antagonist activity of 1,4-dihydropyridines (nifedipine analogous). J Chem Inf Comput Sci 43(4):1328\u20131334","journal-title":"J Chem Inf Comput Sci"},{"issue":"10","key":"76_CR9","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/ardp.200290001","volume":"335","author":"B Hemmateenejad","year":"2002","unstructured":"Hemmateenejad B, Miri R, Akhond M, Shamsipur M (2002) Quantitative structure-activity relationship study of recently synthesized 1,4-dihydropyridine calcium channel antagonists. Application of the Hansch analysis method. Arch Pharm (Weinheim) 335(10):472\u2013480","journal-title":"Arch Pharm (Weinheim)"},{"issue":"10","key":"76_CR10","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/ardp.200600211","volume":"340","author":"M Hosseini","year":"2007","unstructured":"Hosseini M, Miri R, Amini M, Mirkhani H, Hemmateenejad B, Ghodsi S, Alipour E, Shafiee A (2007) Synthesis, QSAR and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing 1-methyl-4, 5-dichloroimidazolyl substituents. Arch Pharm (Weinheim) 340(10):549\u2013556","journal-title":"Arch Pharm (Weinheim)"},{"issue":"14","key":"76_CR11","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1016\/j.bmc.2005.04.066","volume":"13","author":"F Iori","year":"2005","unstructured":"Iori F, da Fonseca R, Ramos MJ, Menziani MC (2005) Theoretical quantitative structure\u2013activity relationships of flavone ligands interacting with cytochrome P450 1A1 and 1A2 isozymes. Bioorg Med Chem 13(14):4366\u20134374","journal-title":"Bioorg Med Chem"},{"issue":"6","key":"76_CR12","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/S0090-9556(24)15316-0","volume":"27","author":"T Kakkar","year":"1999","unstructured":"Kakkar T, Boxenbaum H, Mayersohn M (1999) Estimation of Ki in a competitive enzyme-inhibition model: comparisons among three methods of data analysis. Drug Metab Dispos 27(6):756\u2013762","journal-title":"Drug Metab Dispos"},{"issue":"11\u201312","key":"76_CR13","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s002280050706","volume":"55","author":"M Katoh","year":"2000","unstructured":"Katoh M, Nakajima M, Shimada N, Yamazaki H, Yokoi T (2000) Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: prediction of in vivo drug\u2013drug interactions. Eur J Clin Pharmacol 55(11\u201312):843\u2013852","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"76_CR14","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ejps.2004.12.009","volume":"24","author":"JM Kriegl","year":"2005","unstructured":"Kriegl JM, Eriksson L, Arnhold T, Beck B, Johansson E, Fox T (2005) Multivariate modeling of cytochrome P450 3A4 inhibition. Eur J Pharm Sci 24(5):451\u2013463","journal-title":"Eur J Pharm Sci"},{"issue":"1\u20133","key":"76_CR15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0300-483X(99)00207-3","volume":"144","author":"DF Lewis","year":"2000","unstructured":"Lewis DF (2000) Structural characteristics of human P450s involved in drug metabolism: QSARs and lipophilicity profiles. Toxicology 144(1\u20133):197\u2013203","journal-title":"Toxicology"},{"issue":"1","key":"76_CR16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0887-2333(03)00134-6","volume":"18","author":"DF Lewis","year":"2004","unstructured":"Lewis DF (2004) Quantitative structure-activity relationships (QSARs) for substrates of human cytochromes P450 CYP2 family enzymes. Toxicol In Vitro 18(1):89\u201397","journal-title":"Toxicol In Vitro"},{"key":"76_CR17","unstructured":"Liang Z, Yang K, Chen B (2004) Cholesterol in U937 foam cells assayed in liquid chromatographic-mass spectrometry. Chin J Mod Med 14(20):51\u201353\u00a0+\u00a06"},{"issue":"01","key":"76_CR18","first-page":"11","volume":"18","author":"L Liu","year":"2010","unstructured":"Liu L, Wang W, Yao C (2010) China\u2019s high blood pressure control guidelines (2009 grassroots version). Chin J Hypertens 18(01):11\u201330","journal-title":"Chin J Hypertens"},{"issue":"11","key":"76_CR19","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1016\/j.bmc.2005.03.004","volume":"13","author":"WF McCalmont","year":"2005","unstructured":"McCalmont WF, Patterson JR, Lindenmuth MA, Heady TN, Haverstick DM, Gray LS, Macdonald TL (2005) Investigation into the structure\u2013activity relationship of novel concentration dependent, dual action T-type calcium channel agonists\/antagonists. Bioorg Med Chem 13(11):3821\u20133839","journal-title":"Bioorg Med Chem"},{"issue":"06","key":"76_CR20","first-page":"4","volume":"35","author":"Q Meng","year":"2004","unstructured":"Meng Q, Liu X, Wang G (2004) Metabolic interaction of Cinildipine with some co-administrated drugs in human liver microsomes. J Chin Pharm Univ 35(06):4","journal-title":"J Chin Pharm Univ"},{"issue":"3","key":"76_CR21","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1053\/pcad.2001.29096","volume":"44","author":"J Muntwyler","year":"2001","unstructured":"Muntwyler J, Follath F (2001) Calcium channel blockers in treatment of hypertension. Prog Cardiovasc Dis 44(3):207\u2013216","journal-title":"Prog Cardiovasc Dis"},{"issue":"5","key":"76_CR22","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1248\/bpb.28.882","volume":"28","author":"K Nakamura","year":"2005","unstructured":"Nakamura K, Ariyoshi N, Iwatsubo T, Fukunaga Y, Higuchi S, Itoh K, Shimada N, Nagashima K, Yokoi T, Yamamoto K, Horiuchi R, Kamataki T (2005) Inhibitory effects of nicardipine to cytochrome P450 (CYP) in human liver microsomes. Biol Pharm Bull 28(5):882\u2013885","journal-title":"Biol Pharm Bull"},{"issue":"1","key":"76_CR23","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0190-9622(95)90040-3","volume":"33","author":"PJ Neuvonen","year":"1995","unstructured":"Neuvonen PJ, Suhonen R (1995) Itraconazole interacts with felodipine. J Am Acad Dermatol 33(1):134\u2013135","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"76_CR24","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1248\/bpb.27.415","volume":"27","author":"T Niwa","year":"2004","unstructured":"Niwa T, Shiraga T, Hashimoto T, Kagayama A (2004) Effect of nilvadipine, a dihydropyridine calcium antagonist, on cytochrome P450 activities in human hepatic microsomes. Biol Pharm Bull 27(3):415\u2013417","journal-title":"Biol Pharm Bull"},{"issue":"19","key":"76_CR25","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.jacc.2008.07.055","volume":"52","author":"JM Siller-Matula","year":"2008","unstructured":"Siller-Matula JM, Lang I, Christ G, Jilma B (2008) Calcium-channel blockers reduce the antiplatelet effect of clopidogrel. J Am Coll Cardiol 52(19):1557\u20131563","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"76_CR26","first-page":"1060","volume":"91","author":"JA Staessen","year":"2001","unstructured":"Staessen JA, Thijs L, Celis H, Gasowski J, Wang JG, Fagard RH (2001) Dihydropyridine calcium-channel blockers for antihypertensive treatment in older patients\u2014evidence from the Systolic Hypertension in Europe Trial. S Afr Med J 91(12):1060\u20131068","journal-title":"S Afr Med J"},{"issue":"12","key":"76_CR27","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/S0090-9556(24)13672-0","volume":"28","author":"DM Stresser","year":"2000","unstructured":"Stresser DM, Blanchard AP, Turner SD, Erve JC, Dandeneau AA, Miller VP, Crespi CL (2000) Substrate-dependent modulation of CYP3A4 catalytic activity: analysis of 27 test compounds with four fluorometric substrates. Drug Metab Dispos 28(12):1440\u20131448","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"76_CR28","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.cbi.2004.03.002","volume":"147","author":"J Tang","year":"2004","unstructured":"Tang J, Amin Usmani K, Hodgson E, Rose RL (2004) In vitro metabolism of fipronil by human and rat cytochrome P450 and its interactions with testosterone and diazepam. Chem Biol Interact 147(3):319\u2013329","journal-title":"Chem Biol Interact"},{"issue":"1","key":"76_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2007.01.016","volume":"74","author":"DJ Triggle","year":"2007","unstructured":"Triggle DJ (2007) Calcium channel antagonists: clinical uses\u2014past, present and future. Biochem Pharmacol 74(1):1\u20139","journal-title":"Biochem Pharmacol"},{"issue":"9","key":"76_CR30","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1124\/dmd.106.013607","volume":"35","author":"YJ Yoon","year":"2007","unstructured":"Yoon YJ, Kim KB, Kim H, Seo KA, Kim HS, Cha IJ, Kim EY, Liu KH, Shin JG (2007) Characterization of benidipine and its enantiomers\u2019 metabolism by human liver cytochrome P450 enzymes. Drug Metab Dispos 35(9):1518\u20131524","journal-title":"Drug Metab Dispos"}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-011-0076-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13318-011-0076-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-011-0076-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T14:49:56Z","timestamp":1742050196000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13318-011-0076-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,13]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["76"],"URL":"https:\/\/doi.org\/10.1007\/s13318-011-0076-3","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"value":"0378-7966","type":"print"},{"value":"2107-0180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,13]]}}}